{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:13:12Z","timestamp":1794852792579,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Interstitial cystitis\/bladder pain syndrome (IC\/BPS) is a chronic inflammatory disease of the bladder for which no effective therapy is currently available. Understanding the pathogenesis of IC\/BPS and identifying effective intervention targets are of great clinical importance for its effective treatment. Our work focuses on elucidating the key targets and underlying mechanisms of IC\/BPS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We established an experimental autoimmune cystitis (EAC) mouse model and generated gene knockout mice to elucidate key mediators triggering chronic inflammatory damage in IC\/BPS through using single-cell RNA sequencing, proteomic sequencing, and molecular biology experiments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our study revealed that the infiltration and activation of macrophages, T cells, and mast cells exacerbated inflammatory bladder damage in both IC\/BPS and EAC mice. Notably, cell-cell communication among bladder immune cells was significantly enhanced in EAC mice. Macrophages, as the main cell types altered in EAC mice, received and transmitted the most intensity signalling. Mechanistically, macrophages synthesized and secreted S100A9, which in turn facilitated macrophage polarization and promoted the production of pro-inflammatory cytokines. S100A9 emerged as an important pro-inflammatory and pathogenic molecule in IC\/BPS and EAC. Further analysis demonstrated that S100A9 activation enhanced the inflammatory response and exacerbated bladder tissue damage in IC\/BPS patients and EAC mice via TLR4\/NF-\u03baB and TLR4\/p38 signalling pathways. Importantly, inhibition of S100A9 with paquinimod, as well as genetic knockout of S100A9, significantly attenuated the pathological process.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>S100A9 is an important pro-inflammatory and pathogenic molecule in IC\/BPS and EAC. Targeting S100A9-initiated signalling pathways may offer a novel therapeutic strategy for IC\/BPS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40364-025-00763-5","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T14:14:32Z","timestamp":1746800072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["S100A9 as a potential novel target for experimental autoimmune cystitis and interstitial cystitis\/bladder pain syndrome"],"prefix":"10.1186","volume":"13","author":[{"given":"Jiang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Wuyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"issue":"6","key":"763_CR1","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.juro.2011.03.064","volume":"185","author":"PM Hanno","year":"2011","unstructured":"Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. J Urol. 2011;185(6):2162\u201370.","journal-title":"J Urol"},{"issue":"1","key":"763_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/JU.0000000000002756","volume":"208","author":"JQ Clemens","year":"2022","unstructured":"Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. J Urol. 2022;208(1):34\u201342.","journal-title":"J Urol"},{"issue":"2","key":"763_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.juro.2011.03.132","volume":"186","author":"SH Berry","year":"2011","unstructured":"Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, et al. Prevalence of symptoms of bladder pain syndrome\/interstitial cystitis among adult females in the united States. J Urol. 2011;186(2):540\u20134.","journal-title":"J Urol"},{"issue":"1","key":"763_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.juro.2012.08.088","volume":"189","author":"AM Suskind","year":"2013","unstructured":"Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis\/bladder pain syndrome and chronic prostatitis\/chronic pelvic pain syndrome in men: results of the RAND interstitial cystitis epidemiology male study. J Urol. 2013;189(1):141\u20135.","journal-title":"J Urol"},{"issue":"11\/12","key":"763_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.5489\/cuaj.3892","volume":"10","author":"DA Tripp","year":"2016","unstructured":"Tripp DA, Nickel JC, Krsmanovic A. Depression and catastrophizing predict suicidal ideation in tertiary care patients with interstitial cystitis\/bladder pain syndrome. Can Urol Assoc J. 2016;10(11\/12):383\u20138.","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"763_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5213\/inj.2142084.042","volume":"25","author":"T Ueda","year":"2021","unstructured":"Ueda T, Hanno PM, Saito R, Meijlink JM, Yoshimura N. Current Understanding and future perspectives of interstitial cystitis\/bladder pain syndrome. Int Neurourol J. 2021;25(2):99\u2013110.","journal-title":"Int Neurourol J"},{"issue":"8","key":"763_CR7","doi-asserted-by":"publisher","first-page":"12301","DOI":"10.1002\/jcp.28009","volume":"234","author":"M Karamali","year":"2019","unstructured":"Karamali M, Shafabakhsh R, Ghanbari Z, Eftekhar T, Asemi Z. Molecular pathogenesis of interstitial cystitis\/bladder pain syndrome based on gene expression. J Cell Physiol. 2019;234(8):12301\u20138.","journal-title":"J Cell Physiol"},{"issue":"5","key":"763_CR8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","volume":"193","author":"PM Hanno","year":"2015","unstructured":"Hanno PM, Erickson D, Moldwin R, Faraday MM, American Urological Association. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545\u201353.","journal-title":"J Urol"},{"key":"763_CR9","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1080\/14656566.2018.1505865","volume":"19","author":"AE Dellis","year":"2018","unstructured":"Dellis AE, Papatsoris AG. Bridging pharmacotherapy and minimally invasive surgery in interstitial cystitis\/bladder pain syndrome treatment. Expert Opin Pharmacother. 2018;19:1369\u201373.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"763_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3109\/00365599.2012.669789","volume":"46","author":"AV Andersen","year":"2012","unstructured":"Andersen AV, Granlund P, Schultz A, Talseth T, Hedlund H, Frich L. Long-term experience with surgical treatment of selected patients with bladder pain syndrome\/interstitial cystitis. Scand J Urol Nephrol. 2012;46(4):284\u20139.","journal-title":"Scand J Urol Nephrol"},{"issue":"1","key":"763_CR11","first-page":"25","volume":"34","author":"Y Akiyama","year":"2019","unstructured":"Akiyama Y, Homma Y, Maeda D. Pathology and terminology of interstitial cystitis\/bladder pain syndrome: A review. Histol Histopathol. 2019;34(1):25\u201332.","journal-title":"Histol Histopathol"},{"key":"763_CR12","doi-asserted-by":"publisher","first-page":"747098","DOI":"10.3389\/fmed.2021.747098","volume":"8","author":"HZ Yueh","year":"2021","unstructured":"Yueh HZ, Yang MH, Huang JY, Wei JC. Risk of autoimmune diseases in patients with interstitial cystitis\/bladder pain syndrome: A nationwide Population-Based study in Taiwan. Front Med (Lausanne). 2021;8:747098.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"763_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.eururo.2011.06.028","volume":"61","author":"CZ Altuntas","year":"2012","unstructured":"Altuntas CZ, Daneshgari F, Sakalar C, Goksoy E, Gulen MF, Kavran M, et al. Autoimmunity to uroplakin II causes cystitis in mice: a novel model of interstitial cystitis. Eur Urol. 2012;61(1):193\u2013200.","journal-title":"Eur Urol"},{"issue":"6","key":"763_CR14","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3390\/jcm9061935","volume":"9","author":"SK Saha","year":"2020","unstructured":"Saha SK, Jeon TI, Jang SB, Kim SJ, Lim KM, Choi YJ, et al. Bioinformatics approach for identifying novel biomarkers and their signaling pathways involved in interstitial cystitis\/bladder pain syndrome with Hunner lesion. J Clin Med. 2020;9(6):1935.","journal-title":"J Clin Med"},{"issue":"1","key":"763_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41392-022-00962-8","volume":"7","author":"L Peng","year":"2022","unstructured":"Peng L, Jin X, Li BY, Zeng X, Liao BH, Jin T, et al. Integrating single-cell RNA sequencing with Spatial transcriptomics reveals immune landscape for interstitial cystitis. Signal Transduct Target Ther. 2022;7(1):161.","journal-title":"Signal Transduct Target Ther"},{"issue":"18","key":"763_CR16","first-page":"e21060","volume":"9","author":"F Su","year":"2022","unstructured":"Su F, Zhang W, Meng L, Zhang W, Liu X, Liu X, et al. Multimodal Single-Cell analyses outline the immune microenvironment and therapeutic effectors of interstitial cystitis\/bladder pain syndrome. Adv Sci (Weinh). 2022;9(18):e21060.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"763_CR17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.acuro.2017.09.007","volume":"42","author":"C Di Capua-Sacoto","year":"2018","unstructured":"Di Capua-Sacoto C, Sanchez-Llopis A, Oconnor JE, Martinez-Romero A, Ruiz-Cerd\u00e1 JL. Apoptotic effect as biomarker of disease, severity and follow-up in interstitial cystitis. Actas Urol Esp (Engl Ed). 2018;42(4):262\u20136.","journal-title":"Actas Urol Esp (Engl Ed)"},{"key":"763_CR18","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8\/A9 in inflammation. Front Immunol. 2018;9:1298.","journal-title":"Front Immunol"},{"issue":"3","key":"763_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1189\/jlb.1008647","volume":"86","author":"JM Ehrchen","year":"2009","unstructured":"Ehrchen JM, Sunderk\u00f6tter C, Foell D, Vogl T, Roth J. The endogenous Toll-like receptor 4 agonist S100A8\/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol. 2009;86(3):557\u201366.","journal-title":"J Leukoc Biol"},{"issue":"10","key":"763_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00011-018-1173-4","volume":"67","author":"F Shabani","year":"2018","unstructured":"Shabani F, Farasat A, Mahdavi M, Gheibi N, Calprotectin. (S100A8\/S100A9): a key protein between inflammation and cancer. Inflamm Res. 2018;67(10):801\u201312.","journal-title":"Inflamm Res"},{"issue":"4","key":"763_CR21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00726-010-0528-0","volume":"41","author":"J Goyette","year":"2011","unstructured":"Goyette J, Geczy CL. Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids. 2011;41(4):821\u201342.","journal-title":"Amino Acids"},{"issue":"1","key":"763_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1189\/jlb.0306170","volume":"81","author":"D Foell","year":"2007","unstructured":"Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 2007;81(1):28\u201337.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"763_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12979-024-00432-5","volume":"21","author":"J Zhao","year":"2024","unstructured":"Zhao J, Luo X, Yang C, Yang X, Deng M, Sun B, et al. Chemokine receptor 7 contributes to T- and B-cell filtering in ageing bladder, cystitis and bladder cancer. Immun Ageing. 2024;21(1):33.","journal-title":"Immun Ageing"},{"key":"763_CR24","doi-asserted-by":"crossref","unstructured":"Zhao J, Yang C, Liang B, Gao Y, Luo J, Zheng J et al. Single-cell profiling reveals various types of interstitial cells in the bladder. Cell Prolif. 2023;e13431.","DOI":"10.1111\/cpr.13431"},{"issue":"Pt 1","key":"763_CR25","doi-asserted-by":"publisher","first-page":"126499","DOI":"10.1016\/j.ijbiomac.2023.126499","volume":"253","author":"C Yang","year":"2023","unstructured":"Yang C, Zhao J, Lin C, Gao Y, Luo J, He F, et al. Inhibition of integrin receptors reduces extracellular matrix levels, ameliorating benign prostate hyperplasia. Int J Biol Macromol. 2023;253(Pt 1):126499.","journal-title":"Int J Biol Macromol"},{"key":"763_CR26","doi-asserted-by":"publisher","first-page":"115047","DOI":"10.1016\/j.bcp.2022.115047","volume":"200","author":"J Zhao","year":"2022","unstructured":"Zhao J, Chen S, Yang C, Zhou M, Yang T, Sun B, et al. Activation of CXCL13\/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis\/bladder pain syndrome. Biochem Pharmacol. 2022;200:115047.","journal-title":"Biochem Pharmacol"},{"key":"763_CR27","doi-asserted-by":"publisher","first-page":"716564","DOI":"10.3389\/fimmu.2021.716564","volume":"12","author":"V Kumar","year":"2021","unstructured":"Kumar V, Kiran S, Shamran HA, Singh UP. Differential expression of MicroRNAs correlates with the severity of experimental autoimmune cystitis. Front Immunol. 2021;12:716564.","journal-title":"Front Immunol"},{"issue":"1","key":"763_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s10753-018-0888-2","volume":"42","author":"BK Liu","year":"2019","unstructured":"Liu BK, Jin XW, Lu HZ, Zhang X, Zhao ZH, Shao Y. The effects of Neurokinin-1 receptor antagonist in an experimental autoimmune cystitis model resembling bladder pain syndrome\/interstitial cystitis. Inflammation. 2019;42(1):246\u201354.","journal-title":"Inflammation"},{"issue":"3","key":"763_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/imm.13722","volume":"171","author":"P Xia","year":"2024","unstructured":"Xia P, Ji X, Yan L, Lian S, Chen Z, Luo Y. Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunity. Immunology. 2024;171(3):365\u201376.","journal-title":"Immunology"},{"issue":"12","key":"763_CR30","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1136\/annrheumdis-2014-206517","volume":"74","author":"RF Schelbergen","year":"2015","unstructured":"Schelbergen RF, Geven EJ, van den Bosch MH, Eriksson H, Leanderson T, Vogl T, et al. Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis. Ann Rheum Dis. 2015;74(12):2254\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"763_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCULATIONAHA.118.039262","volume":"140","author":"Y Li","year":"2019","unstructured":"Li Y, Chen B, Yang X, Zhang C, Jiao Y, Li P, et al. S100a8\/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic\/reperfusion injury. Circulation. 2019;140(9):751\u201364.","journal-title":"Circulation"},{"key":"763_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/978-1-0716-1024-4_28","volume":"2228","author":"O Pagel","year":"2021","unstructured":"Pagel O, Kollipara L, Sickmann A. Quantitative proteome data analysis of tandem mass tags labeled samples. Methods Mol Biol. 2021;2228:409\u201317.","journal-title":"Methods Mol Biol"},{"issue":"7","key":"763_CR33","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1074\/mcp.RA118.000620","volume":"17","author":"H Wang","year":"2018","unstructured":"Wang H, Cheng Q, Li X, Hu F, Han L, Zhang H, et al. Loss of TIGAR induces oxidative stress and meiotic defects in oocytes from obese mice. Mol Cell Proteom. 2018;17(7):1354\u201364.","journal-title":"Mol Cell Proteom"},{"key":"763_CR34","doi-asserted-by":"publisher","first-page":"19670","DOI":"10.1038\/srep19670","volume":"6","author":"J Zhao","year":"2016","unstructured":"Zhao J, Wang L, Dong X, Hu X, Zhou L, Liu Q, et al. The c-Jun N terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat Protamine sulfate induced cystitis. Sci Rep. 2016;6:19670.","journal-title":"Sci Rep"},{"issue":"6","key":"763_CR35","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.juro.2008.01.082","volume":"179","author":"JS Starkman","year":"2008","unstructured":"Starkman JS, Martinez-Ferrer M, Iturregui JM, Uwamariya C, Dmochowski RR, Bhowmick NA. Nicotinic signaling ameliorates acute bladder inflammation induced by Protamine sulfate or cyclophosphamide. J Urol. 2008;179(6):2440\u20136.","journal-title":"J Urol"},{"issue":"4","key":"763_CR36","doi-asserted-by":"publisher","first-page":"e0122597","DOI":"10.1371\/journal.pone.0122597","volume":"10","author":"J Zhao","year":"2015","unstructured":"Zhao J, Song Q, Wang L, Dong X, Yang X, Bai X, Damaser M, Li L, et al. Detrusor myocyte autophagy protects the bladder function via inhibiting the inflammation in cyclophosphamide-induced cystitis in rats. PLoS ONE. 2015;10(4):e0122597.","journal-title":"PLoS ONE"},{"issue":"2","key":"763_CR37","doi-asserted-by":"publisher","first-page":"875","DOI":"10.7150\/thno.66420","volume":"12","author":"R Shi","year":"2022","unstructured":"Shi R, Zhao K, Wang T, Yuan J, Zhang D, Xiang W, et al. 5-aza-2\u2019-deoxycytidine potentiates anti-tumor immunity in colorectal peritoneal metastasis by modulating ABC A9-mediated cholesterol accumulation in macrophages. Theranostics. 2022;12(2):875\u201390.","journal-title":"Theranostics"},{"issue":"10","key":"763_CR38","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s12264-022-00902-0","volume":"38","author":"YW Liu","year":"2022","unstructured":"Liu YW, Zhang J, Bi W, Zhou M, Li J, Xiong T, et al. Histones of neutrophil extracellular traps induce CD11b expression in brain pericytes via Dectin-1 after traumatic brain injury. Neurosci Bull. 2022;38(10):1199\u2013214.","journal-title":"Neurosci Bull"},{"issue":"4","key":"763_CR39","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00192-022-05224-3","volume":"34","author":"J Zhao","year":"2023","unstructured":"Zhao J, Lu Q, Yang Z, Sun B, Zhu J, Zhang H, et al. Decreased autophagic activity of detrusor cells is involved in the inflammatory response of interstitial cystitis\/bladder pain syndrome. Int Urogynecol J. 2023;34(4):843\u201351.","journal-title":"Int Urogynecol J"},{"key":"763_CR40","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/MCB.23.3.1034-1043.2003","volume":"23","author":"MP Manitz","year":"2003","unstructured":"Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, Gunzer M, et al. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol. 2003;23:1034\u201343.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"763_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ucl.2022.01.003","volume":"49","author":"CJ Chermansky","year":"2022","unstructured":"Chermansky CJ, Guirguis MO. Pharmacologic management of interstitial cystitis\/bladder pain syndrome. Urol Clin North Am. 2022;49(2):273\u201382.","journal-title":"Urol Clin North Am"},{"issue":"10","key":"763_CR42","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","volume":"70","author":"A Jukic","year":"2021","unstructured":"Jukic A, Bakiri L, Wagner EF, Tilg H, Adolph TE. Calprotectin: from biomarker to biological function. Gut. 2021;70(10):1978\u201388.","journal-title":"Gut"},{"issue":"2","key":"763_CR43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1871530315666150316123854","volume":"15","author":"T Leanderson","year":"2015","unstructured":"Leanderson T, Liberg D, Ivars F. S100A9 as a Pharmacological target molecule in inflammation and cancer. Endocr Metab Immune Disord Drug Targets. 2015;15(2):257\u20132677.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"763_CR44","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/s41467-021-23482-5","volume":"12","author":"H Atcha","year":"2021","unstructured":"Atcha H, Jairaman A, Holt JR, Meli VS, Nagalla RR, Veerasubramanian PK, et al. Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing. Nat Commun. 2021;12(1):3256.","journal-title":"Nat Commun"},{"issue":"1","key":"763_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11(1):102.","journal-title":"Nat Commun"},{"issue":"1","key":"763_CR46","doi-asserted-by":"publisher","first-page":"102927","DOI":"10.1016\/j.autrev.2021.102927","volume":"21","author":"A Jena","year":"2022","unstructured":"Jena A, Mishra S, Deepak P, Kumar-M P, Sharma A, Patel YI, et al. Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: systematic review and meta-analysis. Autoimmun Rev. 2022;21(1):102927.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"763_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5644\/ama2006-124.295","volume":"49","author":"UC Kucuksezer","year":"2020","unstructured":"Kucuksezer UC, Ozdemir C, Akdis M, Akdis CA. Influence of innate immunity on immune tolerance. Acta Med Acad. 2020;49(2):164\u201380.","journal-title":"Acta Med Acad"},{"key":"763_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.coi.2020.10.013","volume":"67","author":"DE Place","year":"2020","unstructured":"Place DE, Kanneganti TD. The innate immune system and cell death in autoinflammatory and autoimmune disease. Curr Opin Immunol. 2020;67:95\u2013105.","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"763_CR49","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41573-019-0025-4","volume":"18","author":"WJM Mulder","year":"2019","unstructured":"Mulder WJM, Ochando J, Joosten LAB, Fayad ZA, Netea MG. Therapeutic targeting of trained immunity. Nat Rev Drug Discov. 2019;18(7):553\u201366.","journal-title":"Nat Rev Drug Discov"},{"key":"763_CR50","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1038\/ncomms5593","volume":"5","author":"T Vogl","year":"2014","unstructured":"Vogl T, Eisenbl\u00e4tter M, V\u00f6ller T, Zenker S, Hermann S, van Lent P, et al. Alarmin S100A8\/S100A9 as a biomarker for molecular imaging of local inflammatory activity. Nat Commun. 2014;5:4593.","journal-title":"Nat Commun"},{"key":"763_CR51","doi-asserted-by":"publisher","first-page":"1001025","DOI":"10.3389\/fimmu.2022.1001025","volume":"13","author":"J Inciarte-Mundo","year":"2022","unstructured":"Inciarte-Mundo J, Frade-Sosa B, Sanmart\u00ed R. From bench to bedside: calprotectin (S100A8\/S100A9) as a biomarker in rheumatoid arthritis. Front Immunol. 2022;13:1001025.","journal-title":"Front Immunol"},{"issue":"3","key":"763_CR52","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ajpath.2021.12.002","volume":"192","author":"K anigawa","year":"2022","unstructured":"anigawa K, Tsukamoto S, Koma YI, Kitamura Y, Urakami S, Shimizu M, et al. S100A8\/A9 induced by interaction with macrophages in esophageal squamous cell carcinoma promotes the migration and invasion of cancer cells via Akt and p38 MAPK pathways. Am J Pathol. 2022;192(3):536\u201352.","journal-title":"Am J Pathol"},{"key":"763_CR53","doi-asserted-by":"crossref","unstructured":"Goyette J, Geczy CL. Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids., Cotoi S. S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease. Mediators Inflamm. 2013:2013:828354.","DOI":"10.1155\/2013\/828354"},{"key":"763_CR54","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cca.2019.11.019","volume":"502","author":"X Xiao","year":"2020","unstructured":"Xiao X, Yang C, Qu SL, Shao YD, Zhou CY, Chao R, et al. S100 proteins in atherosclerosis. Clin Chim Acta. 2020;502:293\u2013304.","journal-title":"Clin Chim Acta"},{"key":"763_CR55","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3389\/fimmu.2020.01258","volume":"11","author":"JS Lee","year":"2020","unstructured":"Lee JS, Lee NR, Kashif A, Yang SJ, Nam AR, Song IC, et al. S100A8 and S100A9 promote apoptosis of chronic eosinophilic leukemia cells. Front Immunol. 2020;11:1258.","journal-title":"Front Immunol"},{"issue":"6","key":"763_CR56","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1248\/bpb.26.753","volume":"26","author":"S Yui","year":"2003","unstructured":"Yui S, Nakatani Y, Mikami M, Calprotectin. (S100A8\/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull. 2003;26(6):753\u201360.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"763_CR57","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13075-021-02573-0","volume":"23","author":"R Hesselstrand","year":"2021","unstructured":"Hesselstrand R, Distler JHW, Riemekasten G, Wuttge DM, T\u00f6rngren M, Nyhl\u00e9n HC, et al. An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod. Arthritis Res Ther. 2021;23(1):204.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"763_CR58","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/art.33493","volume":"64","author":"AA Bengtsson","year":"2012","unstructured":"Bengtsson AA, Sturfelt G, Lood C, R\u00f6nnblom L, van Vollenhoven RF, Axelsson B, et al. Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus. Arthritis Rheum. 2012;64(5):1579\u201388.","journal-title":"Arthritis Rheum"},{"key":"763_CR59","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejogrb.2022.03.023","volume":"272","author":"G D\u2019Alessandro","year":"2022","unstructured":"D\u2019Alessandro G, Palmieri S, Cola A, Barba M, Manodoro S, Frigerio M. Correlation between urinary symptoms and urodynamic findings: is the bladder an unreliable witness? Eur J Obstet Gynecol Reprod Biol. 2022;272:130\u20133.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"763_CR60","doi-asserted-by":"crossref","unstructured":"Lewis P, Abrams P. Urodynamic protocol and central review of data for clinical trials in lower urinary tract dysfunction. BJU Int. 2000 Mar;85(Suppl 1):20\u201330.","DOI":"10.1046\/j.1464-410X.2000.00020.x"},{"issue":"1","key":"763_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tjog.2019.11.005","volume":"59","author":"CC Hsu","year":"2020","unstructured":"Hsu CC, Liang CC, Chang SD, Chien CW, Hsieh WC. Comparison of urodynamic results and quality of life between women with interstitial cystitis and overactive bladder. Taiwan J Obstet Gynecol. 2020;59(1):39\u201342.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"2","key":"763_CR62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00192-009-1015-6","volume":"21","author":"DN Sastry","year":"2010","unstructured":"Sastry DN, Hunter KM, Whitmore KE. Urodynamic testing and interstitial cystitis\/painful bladder syndrome. Int Urogynecol J. 2010;21(2):157\u201361.","journal-title":"Int Urogynecol J"},{"key":"763_CR63","doi-asserted-by":"publisher","first-page":"F589","DOI":"10.1152\/ajprenal.00628.2009","volume":"298","author":"L Arms","year":"2010","unstructured":"Arms L, Girard BM. Expression and function of CXCL12\/CXCR4 in rat urinary bladder with cyclophosphamide-induced cystitis. Am J Physiol Ren Physiol. 2010;298:F589\u2013600.","journal-title":"Am J Physiol Ren Physiol"},{"key":"763_CR64","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.autneu.2006.02.030","volume":"126\u2013127","author":"R Yuridullah","year":"2006","unstructured":"Yuridullah R, Corrow KA. Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis. Auton Neurosci. 2006;126\u2013127:380\u20139.","journal-title":"Auton Neurosci"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00763-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-025-00763-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00763-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T15:03:29Z","timestamp":1746803009000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-025-00763-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1186\/s40364-025-00763-5","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Council and Animal Care and Use Committee of the Army Military Medical University, China (Approval No.: AMUWEC2019414) and was conducted in accordance with animal welfare guidelines and the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to the publication of the article. Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}